Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
PRHSX vs Invesco V.I. Health Care Fund
Shared holdings
53
PRHSX covered by B
48.06%
B covered by PRHSX
48.06%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
PRHSX (March 31, 2026)
| Security | Weight | |
|---|---|---|
| LILLY ELI and CO | 10.14% | |
| THERMO FISHER SCIENTIFIC INC | 4.07% | |
| INTUITIVE SURGICAL INC | 3.65% | |
| STRYKER CORP | 3.46% | |
| MERCK & CO | 3.44% | |
| ASTRAZENECA PLC | 3.17% | |
| UNITEDHEALTH GRP | 3.09% | |
| ARGENX SE SPONSORED ADR | 2.92% | |
| ABBVIE INC | 2.84% | |
| REGENERON PHARMACEUTICALS INC | 2.65% | |
| GILEAD SCIENCES INC | 2.60% | |
| JOHNSON&JOHNSON | 2.44% | |
| VERTEX PHARMACEUTICALS INC | 2.43% | |
| DANAHER CORP | 2.05% | |
| ALNYLAM PHARMACEUTICALS INC | 1.62% | |
| Ascendis Pharma A/S | 1.42% | |
| REVOLUTION MEDICINES INC | 1.36% | |
| UNITED THERAPEUTICS CORP DEL | 1.34% | |
| BEONE MEDICINE-H | 1.19% | |
| ROIVANT SCIENCES LTD | 1.13% | |
| PROTAGONIST THERAPEUTICS INC | 1.11% | |
| INSMED INC | 1.06% | |
| SUMMIT THERAPEUTICS INC | 1.04% | |
| NATERA INC | 1.03% | |
| TENET HEALTHCARE CORP | 1.01% | |
| BRIGHTSPRING HEALTH SERVICES INC | 0.98% | |
| AMGEN INC | 0.98% | |
| BOSTON SCIENTIFIC CORP | 0.92% | |
| HCA HEALTHCARE INC | 0.90% | |
| GUARDANT HEALTH INC | 0.90% | |
| CVS HEALTH CORP | 0.86% | |
| KYMERA THERAPEUTICS INC | 0.77% | |
| THE CIGNA GROUP | 0.74% | |
| CG ONCOLOGY INC | 0.69% | |
| CARDINAL HEALTH INC | 0.68% | |
| ELEVANCE HEALTH INC | 0.66% | |
| KRYSTAL BIOTECH INC | 0.65% | |
| SCHOLAR ROCK HOLDING CORP | 0.62% | |
| IONIS PHARMACEUTICALS INC | 0.61% | |
| BRIDGEBIO PHARMA INC | 0.59% | |
| CHUGAI PHARMA CO | 0.58% | |
| STRUCTURE THERAPEUTICS INC ADR | 0.56% | |
| PRAXIS PRECISION MEDICINES INC | 0.56% | |
| CELCUITY INC | 0.56% | |
| ROYALTY PHARMA PLC | 0.55% | |
| CENCORA INC | 0.52% | |
| CENTESSA PHARMACEUTICALS LTD ADR | 0.50% | |
| VERA THERAPEUTICS INC | 0.46% | |
| NUVALENT INC-A | 0.43% | |
| APOGEE THERAPEUTICS INC | 0.43% |
Invesco V.I. Health Care Fund (March 31, 2026)
| Security | Weight | |
|---|---|---|
| LILLY ELI and CO | 8.79% | |
| JOHNSON&JOHNSON | 5.59% | |
| AstraZeneca PLC ORD USD0.25 | 4.19% | |
| GILEAD SCIENCES INC | 3.96% | |
| ABBVIE INC | 3.58% | |
| CENCORA INC | 3.51% | |
| MCKESSON CORP | 3.47% | |
| ARGENX SE SPONSORED ADR | 3.26% | |
| Invesco Private Prime Fund | 2.77% | |
| Invesco Treasury Portfolio, Institutional Class | 2.38% | |
| MERCK & CO | 2.18% | |
| WELLTOWER INC | 2.01% | |
| HCA HEALTHCARE INC | 1.97% | |
| VERTEX PHARMACEUTICALS INC | 1.92% | |
| ROYALTY PHARMA-A | 1.78% | |
| BRIGHTSPRING HEALTH SERVICES INC | 1.73% | |
| INSMED INC | 1.66% | |
| CARDINAL HEALTH INC | 1.62% | |
| REGENERON PHARMACEUTICALS INC | 1.62% | |
| THERMO FISHER SCIENTIFIC INC | 1.50% | |
| UCB SA | 1.48% | |
| GUARDANT HEALTH INC | 1.48% | |
| NATERA INC | 1.45% | |
| IDEXX LABS INC | 1.38% | |
| BRIDGEBIO PHARMA INC | 1.35% | |
| UNITEDHEALTH GRP | 1.35% | |
| AXSOME THERAPEUTICS INC | 1.25% | |
| Invesco Government & Agency Portfolio, Institutional Class | 1.24% | |
| INTUITIVE SURGICAL INC | 1.19% | |
| UNITED THERAPEUTICS CORP DEL | 1.15% | |
| SANDOZ GRP. AG | 1.12% | |
| METTLER-TOLEDO INTL INC | 1.11% | |
| EDWARDS LIFESCIENCES CORP | 1.07% | |
| Invesco Private Government Fund | 1.07% | |
| BOSTON SCIENTIFIC CORP | 1.06% | |
| Ascendis Pharma A/S | 1.05% | |
| TENET HEALTHCARE CORP | 1.04% | |
| ENCOMPASS HEALTH CORP | 0.96% | |
| MADRIGAL PHARMACEUTICALS INC | 0.93% | |
| PROTAGONIST THERAPEUTICS INC | 0.92% | |
| CVS HEALTH CORP | 0.92% | |
| MEDLINE INC-A | 0.85% | |
| HALOZYME THERAPEUTICS INC | 0.84% | |
| GALDERMA GRP. AG | 0.82% | |
| LONZA GRP. AG | 0.80% | |
| LIGAND PHARMACEUTICALS | 0.77% | |
| IONIS PHARMACEUTICALS INC | 0.68% | |
| GLOBUS MEDICAL INC | 0.64% | |
| STERIS PLC | 0.62% | |
| LABCORP HOLDINGS INC | 0.61% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.